Literature DB >> 30850332

Intraoperative brachytherapy for resected brain metastases.

Sean S Mahase1, Kristina Navrazhina1, Theodore H Schwartz2, Bhupesh Parashar3, A Gabriella Wernicke4.   

Abstract

Brain metastases are the most common intracranial malignancies in adults. Surgical resection is the preferred treatment approach when a pathological diagnosis is required, for symptomatic patients who are refractory to steroids, and to decompress lesions causing mass effect. Radiotherapy is administered to improve local control rates after surgical resection. After a brief review of the literature describing the treatment of brain metastases using whole-brain radiotherapy, postoperative stereotactic radiosurgery, preoperative radiosurgery, and brachytherapy, we compare patient-related, technical, practical, and radiobiological considerations of each technique. Finally, we focus our discussion on intraoperative brachytherapy, with an emphasis on the technical aspects, benefits, efficacy, and outcomes of studies utilizing permanent Cs-131 implants.
Copyright © 2019 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Brain metastases

Mesh:

Substances:

Year:  2019        PMID: 30850332     DOI: 10.1016/j.brachy.2019.01.011

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  8 in total

Review 1.  Brachytherapy for central nervous system tumors.

Authors:  Evan D Bander; Jonathan P S Knisely; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2022-05-11       Impact factor: 4.130

Review 2.  The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.

Authors:  Paolo Palmisciano; Ali S Haider; Kishore Balasubramanian; Randy S D'Amico; Alla Gabriella Wernicke
Journal:  J Neurooncol       Date:  2022-06-13       Impact factor: 4.506

Review 3.  Review of Current Principles of the Diagnosis and Management of Brain Metastases.

Authors:  Alex W Brenner; Akash J Patel
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

Review 4.  Evolving Strategies to Potentially Further Optimize Surgical Interventions in Brain Cancer.

Authors:  Bindi B Parikh; Elizabeth C Neil
Journal:  Curr Oncol Rep       Date:  2020-03-06       Impact factor: 5.075

5.  Proposed brachytherapy recommendations (practical implementation, indications, and dose fractionation) during COVID-19 pandemic.

Authors:  Pranshu Mohindra; Sushil Beriwal; Mitchell Kamrava
Journal:  Brachytherapy       Date:  2020-05-01       Impact factor: 2.362

Review 6.  Effects of Radiation Therapy on Neural Stem Cells.

Authors:  Anna Michaelidesová; Jana Konířová; Petr Bartůněk; Martina Zíková
Journal:  Genes (Basel)       Date:  2019-08-24       Impact factor: 4.096

7.  Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.

Authors:  Brandon S Imber; Robert J Young; Kathryn Beal; Anne S Reiner; Alexandra M Giantini-Larsen; Simone Krebs; Jonathan T Yang; David Aramburu-Nunez; Gil'ad N Cohen; Cameron Brennan; Viviane Tabar; Nelson S Moss
Journal:  J Neurooncol       Date:  2022-07-27       Impact factor: 4.506

Review 8.  GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors.

Authors:  Chukwuyem Ekhator; Ijeoma Nwankwo; Elya Rak; Ariel Homayoonfar; Ekokobe Fonkem; Ramin Rak
Journal:  Cureus       Date:  2022-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.